`Tel: 571-272-7822
`
`Paper 68
`Date: April 7, 2020
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`
`
`
`
`
`
`
`
`
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`
`CARDIOVASCULAR SYSTEMS, INC.
`Petitioner,
`
`v.
`
`SHOCKWAVE MEDICAL, INC.,
`Patent Owner.
`
`
`IPR2019-00409
`Patent 8,728,091 B2
`
`
`Before MITCHELL WEATHERLY, RICHARD MARSCHALL, and
`AVELYN M. ROSS, Administrative Patent Judges.
`
`ROSS, Administrative Patent Judge.
`
`ORDER
`Conduct of the Proceeding
`37 C.F.R. §§ 42.14 and 42.54
`
`
`
`
`
`
`
`
`
`IPR2019-00409
`Patent 8,728,091 B2
`
`On March 18, 2020, Petitioner filed a motion to seal portions of
`
`Exhibit 1365, the deposition transcript of Dr. Morten Olgaard Jensen, dated
`
`February 24, 2020. Paper 58 (“Motion to Seal”). Petitioner represents that
`
`“Counsel for petitioner and patent owner conferred on March 17, 2020 and
`
`patent owner does not oppose this motion.” Id. at 2.
`
`A motion to seal may be granted for “good cause.” 37 C.F.R. § 42.54.
`
`The Board has a strong public interest in the public availability of the
`
`proceedings. Our rules are intended to “strike a balance between the
`
`public’s interest in maintaining a complete and understandable file history
`
`and the parties’ interest in protecting truly sensitive information.” Office
`
`Patent Trial Practice Guide, 77 Fed. Reg. 48,756, 48,760 (Aug. 14, 2012)
`
`(“Trial Practice Guide”). The Trial Practice Guide explains that “the rules
`
`identify confidential information in a consistent with the Federal Rules of
`
`Civil Procedure 26(c)(1)(G), which provides for protective orders for trade
`
`secret or other confidential research, development, or commercial
`
`information.” Id. We previously entered Paper 57 as the Protective Order in
`
`this proceeding. See Paper 67.
`
`A redacted version of Exhibit 1365 was submitted by Patent Owner as
`
`Exhibit 2205. Motion to Seal 1. Petitioner explains that Dr. Jensen’s
`
`testimony about “the relationship between his previous employer and the
`
`identified companies is confidential and remains confidential to his
`
`knowledge.” Id. at 2. Furthermore, Petitioner states that Dr. Jensen
`
`“disclosed the names after being told the information would remain
`
`confidential in these proceedings.” Id. Petitioner also argues that the
`
`redactions “are minimal and the record remains understandable to the public
`
`with the limited redactions.” Id.
`
`2
`
`
`
`IPR2019-00409
`Patent 8,728,091 B2
`
`Having considered the arguments and evidence, we are persuaded that
`
`Petitioner has made a sufficient showing that the specified portions of
`
`unredacted Exhibit 1365 contains confidential, proprietary, or trade secret
`
`information. We therefore, grant the Motion to Seal Exhibit 1365.
`
`We remind the parties that information subject to a protective order
`
`will become public if identified in a final written decision in this proceeding
`
`and that a motion to expunge such information will not necessarily prevail
`
`over the public interest in maintaining a complete and understandable file
`
`history for the challenged patent. See Trial Practice Guide at 48,760–61.
`
`ORDERED that the Motion to Seal unredacted Exhibit 1365 is
`
`ORDER
`
`granted.
`
`
`
`3
`
`
`
`IPR2019-00409
`Patent 8,728,091 B2
`
`PETITIONER:
`Mark C. Nelson
`Jeffrey Stone
`mstone@btlaw.com
`jstone@btlaw.com
`
`
`PATENT OWNER:
`Greg H. Gardella
`Natalie J. Grace
`Ruth G. Davila
`W. Cook Alciati
`GARDELLA GRACE P.A.
`ggardella@gardellagrace.com
`ngrace@gardellagrace.com
`rdavila@gardellagrace.com
`calciati@gardellagrace.com
`
`Michael Stallman
`Morrison & Foerster LLP
`mstallman@mofo.com
`
`
`4
`
`